Alterations in locomotor activity during chronic cocaine administration: Effect on dopamine receptors and interaction with opioids

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 1, 1998, Pages 277-284

  Kunko, Paul M ^a   French, Dawn ^a   Izenwasser, Sari ^a,b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENYLATE CYCLASE; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR; MORPHINE; NALTREXONE; OPIATE AGONIST; OPIATE ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SENSITIZATION; DRUG TOLERANCE; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADENYLATE CYCLASE; ANALGESICS, OPIOID; ANIMALS; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME ACTIVATION; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE;

EID: 0031957370     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Bain GT and Kornetsky C (1987) Naloxone attenuation of the effect of cocaine on rewarding brain stimulation. Life Sci 40:1119-1125.
2. 2/1c agonist DOI. Biol Psychiatry 34:576-577.
3. Brown BL, Albano JDM, Ekins RP, Sgherzi AM and Tampion W (1971) A simple and sensitive saturation assay method for measurement of adenosine 3′,5′-cyclic monophosphate. Biochem J 121:561-562.
4. Cass WA and Zahniser NR (1993) Cocaine levels in striatum and nucleus accumbens: augmentation following challenge injection in rats withdrawn from repeated cocaine administration. Neurosci Lett 152:177-180.
5. Corrigall WA and Coen KM (1991) Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology 104:167-170.
6. Dykstra LA, Doty P, Johnson AB and Picker MJ (1992) Discriminative stimulus properties of cocaine, alone and in combination with buprenorphine, morphine and naltrexone. Drug Alcohol Dependence 30:227-234.
7. French D and Izenwasser S (1996) Tolerance and sensitization to cocaine are mediated via independent mechanisms. Soc Neurosci Abstr 22:921.
8. Hammer RP Jr (1989) Cocaine alters opiate receptor binding in critical brain reward regions. Synapse 3:55-60.
9. 1 dopamine receptor sensitivity within the rat nucleus accumbens. J Pharmacol Exp Ther 258:882-890.
10. Houdi AA, Bardo MT and Loon GRv. (1989) Opioid mediation of cocaine-induced hyperactivity and reinforcement. Brain Res 497:195-198.
11. Hubner CB, Bain GT and Kornetsky C (1987) The combined effect of morphine and d-amphetamine on the threshold for brain-stimulation reward. Pharmacol Biochem Behav 28:311-315.
12. Inada T, Polk K, Purser C, Hume A, Hoskins B, Ho IK and Rockhold RW (1992) Behavioral and neurochemical effects of continuous infusion of cocaine in rats. Neuropharmacology 31:701-708.
13. Izenwassetr S (1994) Increased mu-opioid efficacy for inhibition of adenylyl cyclase induced by chronic treatment with naltrexone or cocaine. Regul Peptides 54: S119-S120.
14. 3H]dopamine uptake in vitro in rat nucleus accurnbens but not in striatum. Brain Rex 531: 338-341.
15. Izenwasser S and Cox BM (1992) Inhibition of dopamine uptake by cocaine and nicotine: tolerance to chronic treatments. Brain Res 573:119-125.
16. Izenwasser S, Heller B and Cox BM (1996) Continuous cocaine administration enhances μ-but not δ-opioid receptor-mediated inhibition of adenylyl cyclase activity in nucleus accurnbens. Eur J Pharmacol 297:187-191.
17. 1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat. Eur J Pharmacol-Molec Pharmacol Sect 246:39-44.
18. Izenwasser S and Kornetsky C (1989) Effects of amfonelic acid or nisoxetine, alone and in combination with morphine on brain-stimulation reward. Pharmacol Biochem Behav 32:983-986.
19. Kalivas PW, Duffy P, DuMars LA and Skinner C (1988) Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J Pharmacol Exp Ther 245:485-492.
20. Keller RW, Jr, Maisonneuve IM, Carlson JN and Click SD (1992) Within-subject sensitization of striatal dopamine release after a single injection of cocaine: An in vivo microdialysis study. Synapse 11:28-34.
21. King GR, Joyner C and Ellinwood EH, Jr (1994) Continuous or intermittent cocaine administration: Effects of flupenthixol treatment during withdrawal. Pharmacol Biochern Beh 49:883-889.
22. 2 dopamine receptors. Brain Ress 532:265-270.
23. Kleven MS, Woolverton WL and Seiden LS (1988) Lack of long-term monoamine depletions following repeated or continuous exposure to cocaine. Brain Res Bull 21:233-237.
24. Kunko PM. Loeloff RJ and Izenwasser S (1997) Chronic administration of GBR 12909, but not cocaine, produces marked decreases in dopamine transporter density. Naunyn-Schmiedeberg Arch Pharmacol 356: 562-569.
25. Masukawa Y, Suzuki T and Misawa M (1993) Differential modification of the rewarding effects of methamphetainine and cocaine by opioids and antihistamines. Psychopharmacology (Berl) 111:139-143.
26. 1 dopamine receptor function in rat nucleus accumbens and striatum. Brain Res 573:331-335.
27. Mello NK, Mendelson JH, Bree MP and Lukas SE (1990) Buprenorphine and naltrexone effects on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther 254:926-939.
28. Mello NK, Negus SS, Lukas SE, Mendelson JH, Sholar JW and Drieze JM (1995) A primate model of polydrug abuse: Cocaine and heroin combinations. J Pharmacol Exp Ther 274:1325-1337.
29. 3H]benzoylecgonine and pharmacological activity of some cocaine metabolites. J Pharm Pharmacol 27: 784-786.
30. Munson PJ and Rodbard D (1980) Ligand: a versatile approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
31. Orona RA, Mayfield RD, Cline EJ and Zahniser NR (1994) Repeated intravenous cocaine administration to rats produces behavioral sensitization without changing brain cocaine levels. Neurosci Lett 167:121-124.
32. Pan H-T, Menacherry S and Justice JB, Jr (1991) Differences in the pharmacokinetics of cocaine in naive and cocaine-experienced rats. J Neurochem 56:1299-1306.
33. Peris J, Boyson SJ, Cass WA, Curella P, Dwoskin LP, Larson G, Lin L-H, Yasuda RP and Zahniser NR (1990) Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J Pharmacol Exp Ther 253:38-44.
34. Peris J and Zahniser NR (1989) Persistent augmented dopamine release after acute cocaine requires dopamine receptor activation. Pharmacol Biochem Behav 32:71-76.
35. Peterson GL (1977) A simplification of the protein assay method of Lowry et al, which is more generally applicable. Anal Biochem 83:346-356.
36. Pan H-T and Mojaverian P (1991) Steady state concentrations in the nucleus accumbens following two intravenous dosing regimen in rats. Res Commun Substan Abuse 12:185-196.
37. Pettit HO, Pan H-T, Parsons LH and Justice JB, Jr (1990) Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration. J Neurochem 55:798-804.
38. Pettit HO and Pettit AJ (1994) Disposition of cocaine in blood and brain after a single pretreatment. Brain Res 651:261-268.
39. Pilotte NS, Mitchell WM, Sharpe LG, De Souza EB and Dax EM (1991) Chronic cocaine administration and withdrawal of cocaine modify neurotensin binding in rat brain. Synapse 9:111-120.
40. Post RM and Rose H (1976) Increasing effects of repetitive cocaine administration in the rat. Nature (Lond) 260:731-732.
41. Reith MEA, Benuck M and Lajtha A (1987) Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice. J Pharmacol Exp Ther 243:281-287.
42. Sala M, Braida D, Colombo M, Groppetti A, Sacco S, Gori E and Parenti M (1995) Behavioral and biochemical evidence of opioidergic involvement in cocaine sensitization. J Pharmacol Exp Ther 274:450-457.
43. Schuelke GS, Konkol RJ, Terry LC and Madden JA (1995) Effect of cocaine metabolites on behavior: Possible neuroendocrine mechanisms. Brain Res Bull 39:43-48.
44. 1 receptor antagonists. J Med Chem 38:4284-4293.
45. Snedecor GW and Cochran WG (1967) Statistical Methods, 6th ed, Iowa State University Press, Ames, IA.
46. Spealman RD and Bergman J (1992) Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J Pharmacol Exp Ther 261:6117-615.
47. Suzuki T, Mori T, Tsuji M and Misawa M (1995) Interaction between discriminative stimulus effects of cocaine and morphine. Jpn J Pharmacol 67:341-347.
48. Tempel A, Gardner EL and Zukin RS (1985) Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation. J Pharmacol Exp Ther 232:439-444.
49. Unterwald EM, Cox BM, Kreek MJ, Cote TE and Izenwasser S (1993) Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity. Synapse 15:33-38.
50. Unterwald EM, Home-King J and Kreek MJ (1992) Chronic cocaine alters hrain mu opioid receptors. Brain Res 584:314-318.
51. Unterwald EM, Rubenfeld JM and Kreek MJ (1994) Repeated cocaine administration upregulates κ and μ, but not δ, opioid receptors. Neuroreport 5:1613-1616.
52. Yeh SY and DeSouza EB (1991) Lack of neurochemical evidence for neurotoxic effects of repeated cocaine administration in rats on brain monoamine neurons. Drug Alcohol Depend 27:51-61.
53. Zeigler S, Lipton J, Toga A and Ellison G (1991) Continuous cocaine administration produces persisting changes in brain neurochemistry and behavior, Brain Res 552:27-35.